News

Business Wire3d
Elegen and Nutcracker Therapeutics to Pilot First Fully Cell-Free Manufacturing Process for RNA-based Personalized Cancer Therapeutics
Fully cell-free process aims to democratize personalized cancer therapeutics with shorter turnaround and negligible bioburden ...
Conventus Law3d
US – Nonconsensual Third-Party Releases Are Alive And Well In Chapter 15 Despite Purdue.
US - Nonconsensual Third-Party Releases Are Alive And Well In Chapter 15 Despite Purdue. Legal News and Analysis - USA - ...